|
|
Volumn 8, Issue 2, 2002, Pages 143-158
|
|
Ensaculin (KA-672·HCl): A multitransmitter approach to dementia treatment
|
|
Author keywords
5 HT1A; 5HT7; Benzopyranone; Dementia; Ensaculin; Memory; Neuroprotection; Neurotransmitters; NMDA antagonists
|
|
Indexed keywords
2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN;
ALPHA 1 ADRENERGIC RECEPTOR;
ANSECULIN;
BENZOPYRAN DERIVATIVE;
BUTACLAMOL;
CLOZAPINE;
DOPAMINE 2 RECEPTOR;
DOPAMINE 3 RECEPTOR;
HALOPERIDOL;
METHYSERGIDE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NOOTROPIC AGENT;
PHENTOLAMINE;
PRECLAMOL;
SCOPOLAMINE;
SEROTONIN;
SEROTONIN 1A RECEPTOR;
SEROTONIN 7 RECEPTOR;
SPIPERONE;
7 METHOXY 6 (3 (4 (2 METHOXYPHENYL)PIPERAZIN 1 YL)PROPOXY)3,4 DIMETHYL 2H 1 BENZOPYRAN 2 ONE;
7-METHOXY-6-(3-(4-(2-METHOXYPHENYL)PIPERAZIN-1-YL)PROPOXY)3,4-DIMETHYL-2H-1-BENZOPYRAN-2-ONE;
DRD3 PROTEIN, HUMAN;
NEUROPROTECTIVE AGENT;
PIPERAZINE DERIVATIVE;
SEROTONIN 1 RECEPTOR;
SEROTONIN RECEPTOR;
ALZHEIMER DISEASE;
AMNESIA;
AREA UNDER THE CURVE;
AVOIDANCE BEHAVIOR;
BRAIN NERVE CELL;
BRAIN TOXICITY;
CLINICAL TRIAL;
DEMENTIA;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DRUG BLOOD LEVEL;
DRUG BRAIN LEVEL;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
HUMAN;
LEARNING;
MEMORY;
NEUROMODULATION;
NEUROPROTECTION;
NEUROTROPISM;
NONHUMAN;
PASSIVE AVOIDANCE;
PHARMACODYNAMICS;
RECEPTOR AFFINITY;
REVIEW;
TOXICITY TESTING;
ANIMAL;
DRUG ANTAGONISM;
DRUG EFFECT;
SYNAPTIC TRANSMISSION;
ANIMALS;
BENZOPYRANS;
CLINICAL TRIALS;
DEMENTIA;
HUMANS;
MEMORY;
NEUROPROTECTIVE AGENTS;
PIPERAZINES;
RECEPTORS, ADRENERGIC, ALPHA-1;
RECEPTORS, DOPAMINE D2;
RECEPTORS, DOPAMINE D3;
RECEPTORS, N-METHYL-D-ASPARTATE;
RECEPTORS, SEROTONIN;
RECEPTORS, SEROTONIN, 5-HT1;
SYNAPTIC TRANSMISSION;
|
|
EID: 0036023386
PISSN: 1080563X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1527-3458.2002.tb00220.x Document Type: Review |
|
Times cited : (67)
|
|
References (34)
|
